Analyze Diet

Determination of firocoxib in equine plasma using high performance liquid chromatography.

Abstract: A new method of analysis has been developed and validated for the determination of firocoxib, a new nonsteroidal anti-inflammatory drug (NSAID) approved for use in horses and dogs to control pain and inflammation associated with osteoarthritis. Following a liquid extraction using ethyl acetate:hexane (40:60), samples were separated by isocratic reversed-phase HPLC on a Sunfire C(18) column and quantified using UV detection at 290 nm. The mobile phase was a mixture of water with 0.025% trifluoroacetic acid and acetonitrile, with a flow-rate of 1.1 ml/min. The procedure produced a linear curve over the concentration range 5-1500 ng/ml with a lower limit of quantification of 5 ng/ml. Intra- and inter-assay variability was less than 7%. The average recovery was 98%. The method is suitable for the analysis of clinical samples from pharmacokinetic studies and can also be used for small volume sample sizes.
Publication Date: 2010-12-03 PubMed ID: 21185237DOI: 10.1016/j.jchromb.2010.11.026Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research article discusses the development and validation of a new method for determining the presence of firocoxib, a nonsteroidal anti-inflammatory drug, in equine plasma using high performance liquid chromatography.

Objective of the Research

The primary goal of this research was to devise and validate a new analytical process for determining the presence and amount of firocoxib in equine plasma. Firocoxib is an NSAID commonly used in veterinary medicine for pain and inflammation management in horses and dogs, particularly in cases of osteoarthritis.

Methodology

  • The team adopted a liquid extraction process. Ethyl acetate and hexane in a ratio of 40:60 were used for this purpose. Post extraction, samples were separated via an isocratic reversed-phase High Performance Liquid Chromatography (HPLC) approach.
  • The chromatographic separation was performed on a Sunfire C(18) column, a versatile and commonly used column in HPLC due to its ability to withstand a wide range of pH values.
  • To further quantify the amount of firocoxib, ultraviolet (UV) detection was performed at 290 nm.
  • The mobile phase utilized during the method was a mixture of water, containing 0.025% trifluoroacetic acid, and acetonitrile, a powerful polar aprotic solvent that promotes separation of compounds.
  • The flow rate was set at 1.1 ml/min during the experiment.

Results of the Research

  • The method produced a linear response across the concentration range of 5-1500 ng/ml, with the lower limit of quantification set at 5 ng/ml.
  • The variability in the results was found to be less than 7%, both within the same assay (intra-assay variability) and between different assays (inter-assay variability).
  • The average recovery rate was estimated to be 98%, indicating high efficiency of the method.

Implications and Applications

  • Based on the successful results of the research, the developed method proves to be suitable for analyzing clinical samples in pharmacokinetic studies. It provides a reliable method for assessing the amount of medication being absorbed into the horse’s body, how it is being distributed and how quickly it is being eliminated.
  • This method is also advantageous as it can be used for samples of small volumes, thereby reducing the amount of plasma required for the analysis.

Cite This Article

APA
Cox S, Yarbrough J. (2010). Determination of firocoxib in equine plasma using high performance liquid chromatography. J Chromatogr B Analyt Technol Biomed Life Sci, 879(2), 205-208. https://doi.org/10.1016/j.jchromb.2010.11.026

Publication

ISSN: 1873-376X
NlmUniqueID: 101139554
Country: Netherlands
Language: English
Volume: 879
Issue: 2
Pages: 205-208

Researcher Affiliations

Cox, S
  • University of Tennessee, Department of Comparative Medicine, College of Veterinary Medicine, 2407 River Drive, Knoxville, TN 37996, USA. scox6@utk.edu
Yarbrough, J

    MeSH Terms

    • 4-Butyrolactone / analogs & derivatives
    • 4-Butyrolactone / blood
    • Animals
    • Anti-Inflammatory Agents, Non-Steroidal / blood
    • Chromatography, High Pressure Liquid / methods
    • Drug Stability
    • Horses / blood
    • Linear Models
    • Reproducibility of Results
    • Sensitivity and Specificity
    • Sulfonamides / analysis
    • Sulfones / blood

    Citations

    This article has been cited 0 times.